Skip to main content
NCBI home page
Cellular and Molecular Neurobiology logoLink to Cellular and Molecular Neurobiology
. 1991 Feb;11(1):79–89. doi: 10.1007/BF00712801

Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing

Bert N La Du 1, Cynthia F Bartels 1, Christine P Nogueira 1, Martine Arpagaus 1, Oksana Lockridge 1
PMCID: PMC11567217  PMID: 2013061

Abstract

  1. New information identifying nucleotide alterations of human butyrylcholinesterase allows the use of more specific nomenclature for the variants commonly known as atypical, fluoride, silent, and K variant.

  2. In addition to suggesting a system of trivial names and abbreviations, we provide a list of formal names that follow the guidelines of the Committee for Human Gene Nomenclature.

  3. It is suggested that formal names be included in publications whenever possible.

Key words: butyrylcholinesterase, serum cholinesterase, pseudocholinesterase, anionic site, atypical, silent, fluoride resistant, K variant, succinylcholine apnea

References

  1. Arpagaus, M., Kott, M., Vatsis, K. P., Bartels, C. F., La Du, B. N., and Lockridge, O. (1990). Structure of the gene for human butyrylcholinesterase. Evidence for a single copy.Biochemistry29124–131. [DOI] [PubMed] [Google Scholar]
  2. Bartels, C. F., van der Spek, A., Lockridge, O., and La Du, B. N. (1989). A polymorphism (K variant?) of human serum cholinesterase at nucleotide 1615, coding for Ala/Thr 539.FASEB J.3:A741.
  3. Delbruck, A., and Henkel, E. (1979). A rare genetically determined variant of pseudocholinesterase in two German families with high plasma enzyme activity.Eur. J. Biochem.9965–69. [DOI] [PubMed] [Google Scholar]
  4. Eckerson, H. W., Oseroff, A., Lockridge, O., and La Du, B. N. (1983). Immunological comparison of the usual and atypical human serum cholinesterase phenotypes.Biochem. Genet.2193–108. [PubMed] [Google Scholar]
  5. Eiberg, H., Nielsen, L. S., Klausen, J., Dahlen, M., Kristensen, M., Bisgaard, M. L., Moller, N., and Mohr, J. (1989). Linkage between serum cholinesterase 2 (CHE2) andγ-crystallin gene cluster (CRYG): Assignment to chromosome 2.Clin Genet.35313–321. [DOI] [PubMed] [Google Scholar]
  6. Evans, R. T., and Wardell, J. (1984). On the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian population.J. Med. Genet.2199–102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Garry, P. J., Dietz, A. A., Lubrano, T., Ford, P. C., James, K., and Rubinstein, H. M. (1976). New allele at cholinesterase locus 1.J. Med Genet.13 38–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harris, H., and Whittaker, M. (1961). Differential inhibition of human serum cholinesterase with fluoride. Recognition of two new phenotypes.Nature Lond.191496–498. [DOI] [PubMed] [Google Scholar]
  9. Harris, H., Robson, E. B., Glen-Bott, A. M., and Thornton, J. A. (1963). Evidence for non-allelism between genes affecting human serum cholinesterase.Nature2001185–1187. [DOI] [PubMed] [Google Scholar]
  10. Kalow, W. (1962).Pharmacogenetics, Heredity and the Response to Drugs. W. B. Saunders, Philadelphia, pp. 69–93. [Google Scholar]
  11. Kalow, W., and Genest, K. (1957). A method for the detection of atypical forms of human cholinesterase; Determination of dibucaine numbers.Can. J. Biochem. Physiol.35339–346. [DOI] [PubMed] [Google Scholar]
  12. Kalow, W., and Gunn, D. R. (1959). Some statistical data on atypical cholinesterase of human serum.Ann. Hum. Genet.23239–250. [DOI] [PubMed] [Google Scholar]
  13. Kalow, W., and Lindsay, H. A. (1955). A comparison of optical and manometric methods for the assay of human serum cholinesterase.Can. J. Biochem. Physiol.33568–574. [PubMed] [Google Scholar]
  14. Kalow, W., and Staron, N. (1957). On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers.Can. J. Biochem. Physiol.351305–1320. [PubMed] [Google Scholar]
  15. Krause, A., Lane, A. B., and Jenkins, T. (1988). A new high activity plasma cholinesterase variant.J. Med. Genet.25677–681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. La Du, B. N., Bartels, C. F., Nogueira, C. P., Hajra, A., Lightstone, H., van der Spek, A., and Lockridge, O. (1990). Phenotypic and molecular biological analysis of human serum cholinesterase variants.Clin. Biochem.23423–431. [DOI] [PubMed] [Google Scholar]
  17. Liddell, J., Lehmann, H., and Silk, E. (1962). A “silent” pseudocholinesterase gene.Nature (Lond.)193561–562.14465122 [Google Scholar]
  18. Lockridge, O. (1990). Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine.Pharmacol. Ther.4735–60. [DOI] [PubMed] [Google Scholar]
  19. Lockridge, O., and La Du, B. N. (1978). Comparison of atypical and usual human serum cholinesterase: Purification, number of active sites, substrate affinity, and turnover number.J. Biol. Chem.253361–366. [PubMed] [Google Scholar]
  20. Lovrien, E. W., Magenis, R. E., Rivas, M. L., Lamvik, N., Rowe, S., Wood, J., and Hemmerling, J. (1978). Serum cholinesterase (E2) linkage analysis: Possible evidence for localization to chromosome 16.Cytogenet. Cell Genet.22324–325. [DOI] [PubMed] [Google Scholar]
  21. Marazita, M. L., Keats, B. J. B., Spence, M. A., Sparkes, R. S., Field, L. L., Sparkes, M. C., and Crist, M. (1989). Mapping studies of the serum cholinesterase-2 locus (CHE2).Hum. Genet.83139–144. [DOI] [PubMed] [Google Scholar]
  22. Masson, P. (1989). A naturally-occurring molecular form of human plasma cholinesterase is an albumin conjugate.Biochim. Biophys. Acta988258–266. [DOI] [PubMed] [Google Scholar]
  23. Masson, P., Chatonnet, A., and Lockridge, O. (1990). Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant (CHE2).FEBS Lett.262115–118. [DOI] [PubMed] [Google Scholar]
  24. McGuire, M. C., Nogueira, C. P., Bartels, C. F., Lightstone, H., Hajra, A., van der Spek, A. F. L., Lockridge, O., and La Du, B. N. (1989). Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase.Proc. Natl. Acad. Sci. USA86953–957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Neitlich, H. W. (1966). Increased plasma cholinesterase activity and succinylcholine resistance: A genetic variant.J. Clin. Invest.45380–387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nogueira, C. P., McGuire, M. C., Graeser, C., Bartels, C. F., Arpagaus, M., van der Spek, A. F. L., Lightstone, H., Lockridge, O., and La Du, B. N. (1990). Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117, (GGT→GGAG).Am. J. Hum. Genet.46934–942. [PMC free article] [PubMed] [Google Scholar]
  27. Olson, M., Hood, L., Cantor, C., and Botstein, D. (1989). A common language for physical mapping of the human genome.Science2451434–1435. [DOI] [PubMed] [Google Scholar]
  28. Robson, E. B., and Harris, H. (1966). Further data on the incidence and genetics of the serum cholinesterase phenotype C5+.Ann. Hum. Genet. Lond.29403–408. [DOI] [PubMed] [Google Scholar]
  29. Robson, E. B., Sutherland, I., and Harris, H. (1966). Evidence for linkage between the transferrin locus (Tf) and the serum cholinesterase locus (El) in man.Ann. Hum. Genet. Lond.29325–332. [DOI] [PubMed] [Google Scholar]
  30. Rubinstein, H. M., Dietz, A. A., Hodges, L. K., Lubrano, T., and Czebotar, V. (1970). Silent cholinesterase gene: Variations in the properties of serum enzyme in apparent homozygotes.J. Clin. Invest.49479–486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rubinstein, H. M., Dietz, A. A., and Lubrano, T. (1978). E1k, another quantitative variant at cholinesterase locus 1.J. Med. Genet.1527–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Savarese, J. J., Ali, H. H., Basta, S. J., Embree, P. B., Scott, R. P. F., Sunder, N., Weakly, J. N., Wastila, W. B., and El-Sayad, H. A. (1988). The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.Anesthesiology68723–732. [DOI] [PubMed] [Google Scholar]
  33. Scott, E. M., and Powers, R. F. (1974). Properties of the C5 variant form of human serum cholineserase.Am. J. Hum. Genet.26189–194. [PMC free article] [PubMed] [Google Scholar]
  34. Shows, T. B., McAlpine, P. J., Boucheix, C., Collins, F. S., Conneally, P. M., Frezal, J., Gershowitz, H., Goodfellow, P. N., Hall, J. G., Issitt, P., Jones, C. A., Knowles, B. B., Lewis, M., McKusick, V. A., Meisler, M., Morton, N. E., Rubinstein, P., Schanfield, M. S., Schmickel, R. D., Skolnick, M. H., Spence, M. A., Sutherland, G. R., Traver, M., Van Cong, N., and Willard, H. F., (1987). Guidelines for human gene nomenclature. An International System for Human Gene Nomenclature (ISGN, 1987).Cytogenet. Cell Genet.4611–28. [DOI] [PubMed] [Google Scholar]
  35. Simpson, N. E., and Elliott, C. R. (1981). Cholinesterase Newfoundland: A new succinylcholine-sensitive variant of cholinesterase at locu 1.Am. J. Hum. Genet.33366–374. [PMC free article] [PubMed] [Google Scholar]
  36. Soreq, H., Zamir, R., Zevin-Sonkin, D., and Zakut, H. (1987). Human cholinesterase genes localized by hybridization to chromosomes 3 and 16.Hum. Genet.77325–328. [DOI] [PubMed] [Google Scholar]
  37. Sparkes, R. S., Field, L. L., Sparkes, M. C., Crist, M., Spence, M. A., James, K., and Garry, P. J. (1984). Genetic linkage studies of transferrin, pseudocholinesterase, and chromosome 1 loci.Hum. Hered.3496–100. [DOI] [PubMed] [Google Scholar]
  38. Tunek, A., and Svensson, L. A. (1988). Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.Drug Metab. Dispos.16759–764. [PubMed] [Google Scholar]
  39. Viby-Mogensen, J. (1983). Cholinesterase and succinylcholine.Danish Med. Bull.30129–150. [PubMed] [Google Scholar]
  40. Whittaker, M. (1986).Cholinesterase. Monograph in Human Genetics, Vol. 11 Karger, Basel, pp. 1–134. [Google Scholar]
  41. Whittaker, M., and Britten, J. J. (1985). Plasma cholinesterase variants: Family studies of the E1k gene.Hum. Hered.35364–368. [DOI] [PubMed] [Google Scholar]
  42. Whittaker, M., and Britten, J. J. (1987). E1h, a new allele at cholinesterase locus 1.Hum. Hered.3754–58. [DOI] [PubMed] [Google Scholar]
  43. Whittaker, M., and Britten, J. J. (1988). Recognition of two new phenotypes segregating the E1k allele from plasma cholinesterase.Hum. Hered.38233–239. [DOI] [PubMed] [Google Scholar]
  44. Yang, F., Lum, J. B., McGill, J. R., Moore, C. M., Naylor, S. L., Van Bragt, P. H., Baldwin, W. D., and Bowman, B. H. (1984). Human transferrin: cDNA characterization and chromosomal localization.Proc. Natl. Acad. Sci. USA812752–2756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Yoshida, A., and Motulsky, A. G. (1969). A Pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity.Am. J. Hum. Genet.21486–498. [PMC free article] [PubMed] [Google Scholar]
  46. Zakut, H., Zamir, R., Sindel, L., and Soreq, H. (1989). Gene mapping on chorionic villi chromosomes by hybridization in situ: Localization of cholinesterase cDNA binding sites to chromosomes 3q21, 3a26-ter and 16q21.Hum. Reprod.4941–946. [DOI] [PubMed] [Google Scholar]

Articles from Cellular and Molecular Neurobiology are provided here courtesy of Springer

RESOURCES